| Application no. and date | 11717240.3 (espacenet) (Federated) (European Patent Register), 20110425 | | Patent/reg. no. and date | DK/EP 2563904, 20150121 | | Publication date | 20130306 | | Priority no. and date | US 327836 P, 20100426 | | EP pub. no. and date |
EP 2563904 20130306 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | NGC/AP/150415 | | Inventor | SCHMIDT, Jörg, Novartis Pharma AG
Postfach
4002 Basel, CH,
MEISSNER, Petra, Novartis Pharma AG
Postfach
4002 Basel, CH,
LEIST, Christian, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C12N 5/00 (2006.01) | | Title | Forbedret cellekulturmedium | | Int. application no. | EP2011056508 | | Int. publication no. | WO2011134920 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
